in

Faricimab vs Aflibercept in Diabetic Macular Edema

Source link : https://www.newshealth.biz/health-news/faricimab-vs-aflibercept-in-diabetic-macular-edema/

Intraretinal hyperreflective foci, intraretinal hard exudates, and epiretinal membrane formation were lower after treatment with faricimab (Vabysmo) compared with aflibercept (Eylea) for patients with diabetic macular edema (DME), according to an analysis presented at the American Academy of Ophthalmology meeting. In this exclusive MedPage Today video, Jennifer Lim, MD, of the University of Illinois Hospital […]

Author : News Health

Publish date : 2024-11-14 20:18:23

Copyright for syndicated content belongs to the linked Source.

Transforming Logistics: How a Japanese Company Innovates with Seawater Ice

Trump Taps R.F.K. Jr. as New Leader of Health and Human Services: What This Means for America’s Health Policy